Using a standardised protocol was effective in reducing hospitalisation and treatment use in children with newly...

Area of Science:

• Pediatric Hematology
• Immunology
• Clinical Protocol Development

Background:

• Childhood immune thrombocytopenia (ITP) is often associated with spontaneous remission and low bleeding risk.
• Current management frequently involves treatments despite guidelines recommending observation.
• Fear of bleeding complications leads to overtreatment in pediatric ITP.

Purpose of the Study:

• To evaluate the impact of a standardized, step-down management protocol for childhood immune thrombocytopenia (ITP).
• To determine if the protocol reduces hospitalisation rates and the use of platelet-enhancing therapies.
• To assess the effect on disease complications and persistence.

Main Methods:

• Retrospective chart review of pediatric ITP patients before (2010-2012) and after (2013-2014) protocol implementation.
• Analysis of management strategies and clinical events within the first 3 months post-diagnosis.
• Comparison of hospitalisation rates, treatment duration, and complication rates between the two periods.

Main Results:

• The standardized protocol led to a 34% decrease in hospitalisation rates at diagnosis (p < 0.001).
• Prednisone treatment duration was significantly reduced (13.1 vs. 5.8 days, p = 0.004).
• Children over 3 years old were less likely to be hospitalised or treated; no significant difference in persistent ITP or serious bleeding was observed.

Conclusions:

• The implemented ITP management protocol effectively reduced hospitalisation and treatment duration in children.
• The standardized approach achieved these reductions without compromising patient safety or increasing disease complications.
• This protocol offers a viable strategy for optimizing care in pediatric immune thrombocytopenia.